Department of Joint Replacement, General and Rheumatic Orthopaedics, Orthopaedic Clinic Markgröningen gGmbH, Markgröningen, Germany; Department of Orthopaedic Surgery, Medical University of Vienna, Vienna, Austria.
Department of Joint Replacement, General and Rheumatic Orthopaedics, Orthopaedic Clinic Markgröningen gGmbH, Markgröningen, Germany; Orthopaedic Department, University-Hospital Hamburg-Eppendorf, Hamburg, Germany.
J Shoulder Elbow Surg. 2018 Dec;27(12):2175-2182. doi: 10.1016/j.jse.2018.06.004. Epub 2018 Aug 10.
Studies on 1-stage exchange in septic shoulder arthroplasty are limited and show a wide variation of treatment strategies. This retrospective study investigated infection-free survival and function of 1-stage exchange of septic shoulder arthroplasty following a standardized treatment algorithm.
The requirement for 1-stage exchange was an isolated microorganism from synovial fluid aspiration or synovial biopsy with an antibiotic susceptibility profile prior to revision surgery. If no microorganism was isolated or the underlying pathogen was a difficult-to-treat microorganism (not accessible for biofilm-active antibiotics, enterococci, and fungi), 2-stage exchange was performed. Function was assessed by the Constant score.
Fourteen patients were included, with a mean follow-up period of 5.8 years. The most and second most commonly detected microorganisms were Cutibacterium acnes (formerly Propionibacterium acnes), and Staphylococcus epidermidis, respectively. At 1-stage exchange, patients received local and systemic antibiotics based on the susceptibility profile of the microorganism. Twelve patients with insufficient rotator cuffs received reverse shoulder arthroplasty, whereas 2 patients with intact rotator cuffs underwent anatomic total shoulder arthroplasty. The infection-free survival rate at 1 and 5 years was 100% and 93% (95% confidence interval [CI], 59%-99%), respectively, with 1 recurrence of infection 22 months after 1-stage exchange. Another patient with limited range of motion underwent revision 6 months postoperatively, leading to a revision-free survival rate of 93% (95% CI, 59%-99%) and 86% (95% CI, 54%-96%) at 1 and 5 years, respectively. The mean Constant score was 65 (range, 44-95).
One-stage exchange with prior detection of the underlying microorganism provides satisfactory infection-free survival and function.
关于感染性肩关节炎一期翻修的研究有限,且治疗策略差异较大。本回顾性研究按照标准化治疗方案,调查了经关节液抽吸或滑膜活检确定单一微生物且对术前抗生素药敏试验敏感的感染性肩关节炎一期翻修的无感染生存率和功能。
一期翻修的指征为术前关节液抽吸或滑膜活检中分离出单一微生物,且对术前抗生素药敏试验敏感。如果未分离出微生物或潜在病原体为难处理的微生物(对生物膜活性抗生素、肠球菌和真菌无反应),则行二期翻修。采用 Constant 评分评估功能。
共纳入 14 例患者,平均随访 5.8 年。最常见和第二常见的微生物分别为痤疮丙酸杆菌(既往称丙酸杆菌属)和表皮葡萄球菌。一期翻修时,根据微生物的药敏试验结果给予局部和全身抗生素治疗。12 例肩袖不完整的患者接受了反向肩关节置换术,2 例肩袖完整的患者接受了解剖型全肩关节置换术。一期翻修后 1 年和 5 年的无感染生存率分别为 100%和 93%(95%置信区间,59%-99%),1 例患者在一期翻修后 22 个月出现 1 次感染复发。另 1 例活动范围有限的患者术后 6 个月行翻修,导致翻修无生存率分别为 93%(95%置信区间,59%-99%)和 86%(95%置信区间,54%-96%),1 年和 5 年的 Constant 评分分别为 65 分(范围,44-95 分)。
一期翻修时如果能预先确定潜在的微生物,可获得满意的无感染生存率和功能。